Compass Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
OMER
Omeros Corporation |
$10.15 | $797.56 M | -5.57 | 202 |
OCGN
Ocugen, Inc. |
$1.36 | $387.28 M | -5.64 | 95 |
MNPR
Monopar Therapeutics Inc. |
$74.61 | $522.11 M | -19.73 | 14 |
LXRX
Lexicon Pharmaceuticals, Inc. |
$1.30 | $481.50 M | -6.97 | 103 |
KALV
KalVista Pharmaceuticals, Inc. |
$16.91 | $851.71 M | -4.28 | 150 |
GOSS
Gossamer Bio, Inc. |
$3.60 | $795.87 M | -5.08 | 144 |
FULC
Fulcrum Therapeutics, Inc. |
$13.00 | $747.55 M | -8.32 | 45 |
FDMT
4D Molecular Therapeutics, Inc. |
$10.84 | $506.26 M | -2.89 | 227 |
CRVS
Corvus Pharmaceuticals, Inc. |
$8.37 | $633.75 M | -15.72 | 31 |
BCYC
Bicycle Therapeutics plc |
$7.45 | $519.66 M | -2.09 | 305 |